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Sex-related differences in death control of somatic cells
Dear Editor:
In 2001, The United States Institute of Medicine (IOM) Committee on
Understanding the Biology of Sex and Gender Differences concluded
that ‘Sex…should be considered when designing and analysing studies
in all areas and at all levels of biomedical and health-related research…’
and stated an apparent paradox i.e.: ‘every cell has a sex’ [1]. Sex is
defined as ‘the classification of living things, generally as male or female
according to their reproductive organs and functions assigned by chro-
mosomal complement’ whereas gender is defined as ‘a person’s self
representation as male or female, or how that person is responded to by
social institutions based on the individual’s gender presentation. Gender
is rooted in biology and shaped by environment and experience’ [1].
It is unchallenged that there are health differences between males
and females and that social and cultural factors could contribute to
the observed differences. Anyway, the sex-dependent differences also
have a biological base which sometimes has not been deeply investi-
gated. Scientists studying health differences between male and
female aim to both considering social/cultural environment and inves-
tigating biological/molecular mechanisms different between sexes.
Some experimental studies have elucidated important differences in
cell death control [2]. A sex disparity, in fact, has been shown both in
the propensity to apoptosis and in the activation of the autophagic
pathway. In the context of cell fate control, hormones represent
important regulators of both apoptosis and autophagy. In the cardio-
vascular system, for example, oestrogens inhibit cardiomyocyte
apoptosis by decreasing reactive oxygen species production and
increasing intracellular antioxidants [3]. Oestrogens may also indi-
rectly control autophagy as they up-regulate urocortin [4], a neuro-
peptide hormone able to inhibiting autophagy in cardiomyocytes.
Conversely, increasing evidence suggests possible adverse effects of
androgens on the vasculature showing that androgens, as opposed to
oestrogens, may worsen vascular dysfunction in men, thus contribut-
ing to sex-based differences in cardiovascular diseases [5].
However, it is currently emerging that some cell death programs
are differentially controlled by sex-related hormone-independent cel-
lular genetics. Differences in cell death sensitivity in male and female
may then occur in the absence of an hormonal context. This is not an
immediately obvious finding; Penaloza C et al., [6] have shown that
the apoptosis amount differs between the sexes in isolated embryonic
cells exposed to similar conditions and this happens at embryonal
stages where there are no hormonal influences. Previous studies had
reported a sexual dimorphism in embryonic neuronal signal transduc-
tion pathways and consequently differences in cell survival [7]. Death
pathways in XX and XY cells have been poorly investigated as most
studies have been performed on established cells lines often irrespec-
tive of their male or female origin. Recently, using freshly isolated
cells from male and female individuals gave important information on
sex disparity in cell fate control. Such sex specificity has been in part
clarified thanks to cell culture models where sex steroids can be
removed from the media. Even sex-related differences in caspase
activation have been found to be independent on hormone exposure.
More in detail, cell death occurring in cortical neurons after ischaemia
proceeds predominantly via an apoptosis-inducing factor-dependent
pathway (a caspase-independent pathway) in male neurons while pro-
ceeds via a cytochrome C-dependent pathway (a process mediated by
caspase activation) in female neurons [8]. In this context, a sex-spe-
cific microRNA expression after ischaemia has been described in in
vivo studies. In particular, it has been demonstrated that microRNA-
23a, by binding the mRNA of the caspase inhibitor named XIAP,
induces its translational repression in females, leading to enhanced
caspase signalling in the ischaemic female brain. This effect has been
shown to be independent of circulating oestrogen levels [9]. Sex dif-
ferences in ischaemic brain injury and cerebrovascular regulation
have been observed in clinical and experimental studies and an
important determinant of such differences is also represented by the
integrity of endothelial cells. In fact, endothelial function is improved
in women compared with men, contributing to female cellular higher
resistance after ischaemic brain injury. Gupta NC et al. [10] showed
that female cerebrovascular endothelial cells express lower level of
soluble epoxide hydrolase and consequently have higher levels of
vasoprotective epoxyeicosatrienoic acids as compared with male
endothelial cells. This study therefore presents a novel additional
mechanism underlying differences between male and female cells in
apoptotic response after oxygen-glucose deprivation, contributing to
explain higher resistance observed in females as compared with
males. This study remarks again that differences between male and
female cells do not necessarily depend on the hormonal context but
may be inherent the cells. We believe that this apparently paradoxical
concept has not been sufficiently highlighted in the scientific litera-
ture. The present ‘Letter to the Editor’ therefore aims at underlining
such an important issue which deserves more attention and discus-
sion in the researchers’ community. A practical consequence of
sex-dependent discrepancies in cell death control is that cellular
response to any stimulus or treatment, in any physiological or patho-
logical context, may well depend on the sex of the cell line used; jour-
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nals guidelines should therefore require authors to state in any case
the sex of the cell lines used in any in vitro study. In addition, at least
to some extent, sex-matched or sex-unmatched cell controls may be
necessary in many experimental settings. In conclusion, sex-related
differences in cell death mechanism may have strong implications for
experimental studies and sexual dimorphism dependent on chromo-
somal rather than hormonal differences have important implications
for planning preclinical studies and clinical interventions.
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